Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DAGLA | Q9Y4D2 | 12/20 | 0.62 |
| ▸ | PNLIP | P16233 | 3/20 | 0.61 |
| ▸ | CNR1 | P21554 | 10/20 | 0.59 |
| ▸ | MGLL | Q99685 | 1/20 | 0.58 |
| ▸ | CNR2 | P34972 | 1/20 | 0.56 |
| ▸ | DAGLB | Q8NCG7 | 3/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.53 |
| ▸ | ABHD16A | O95870 | 1/20 | 0.53 |
| ▸ | LPL | P06858 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | LIPC | P11150 | 1/20 | 0.53 |
| ▸ | ACHE | P22303 | 1/20 | 0.53 |
| ▸ | FASN | P49327 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | PLA2G7 | Q13093 | 1/20 | 0.53 |
| ▸ | ABHD12 | Q8N2K0 | 1/20 | 0.53 |
| ▸ | ABHD6 | Q9BV23 | 1/20 | 0.53 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL715649 | 0.88 | DAGLA (0.58) | DAGLAPNLIPCNR1MGLLCNR2 | |
| SCHEMBL9031617 | 0.86 | DAGLA (0.60) | DAGLAPNLIPCNR1MGLLCNR2 | |
| SCHEMBL9038457 | 0.85 | DAGLA (0.59) | DAGLAPNLIPCNR1MGLLCNR2 | |
| SCHEMBL9038460 | 0.85 | DAGLA (0.59) | DAGLAPNLIPCNR1MGLLCNR2 | |
| SCHEMBL9038465 | 0.85 | DAGLA (0.59) | DAGLAPNLIPCNR1MGLLCNR2 | |
| SCHEMBL9031854 | 0.84 | DAGLA (0.63) | DAGLAPNLIPCNR1MGLLCNR2 | |
| SCHEMBL9031848 | 0.84 | DAGLA (0.61) | DAGLAPNLIPCNR1MGLLCNR2 | |
| SCHEMBL26373881 | 0.80 | DAGLA (0.71) | DAGLAPNLIPCNR1DAGLBMEN1 | |
| Methyl Alcohol SCHEMBL27962463 | 0.80 | DAGLA (0.65) | DAGLAPNLIPCNR1MGLLCNR2 | |
| SCHEMBL537727 | 0.79 | DAGLA (0.64) | DAGLAPNLIPCNR1MGLLCNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8124794-B2 | Method for the asymmetric synthesis of beta-lactone compounds | SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE (US) | 2012-02-28 | — | — | US | disclosed |
| US-7799826-B2 | Inhibition of fatty acid synthase by beta-lactones and other compounds for inhibition of cellular proliferation | BURNHAM INSTITUTE FOR MEDICAL RESEARCH (US) | 2010-09-21 | — | — | US | disclosed |
| US-20100173982-A1 | NOVEL METHOD FOR THE ASYMMETRIC SYNTHESIS OF BETA-LACTONE COMPOUNDS | THE BURNHAM INSTITUTE FOR MEDICAL RESEARCH (US) | 2010-07-08 | — | — | US | disclosed |
| US-7728153-B2 | Method for the asymmetric synthesis of beta-lactone compounds | THE BURNHAM INSTITUTE FOR MEDICAL RESEARCH (US) | 2010-06-01 | — | — | US | disclosed |
| US-20060258620-A1 | Novel method for the asymmetric synthesis of beta-lactone compounds | BURNHAM INSTITUTE FOR MEDICAL RESEARCH (US) | 2006-11-16 | — | — | US | disclosed |
| US-20040024050-A1 | Inhibition of fatty acid synthase by beta-lactones and other compounds for inhibition of cellular proliferation | BURNHAM INSTITUTE FOR MEDICAL RESEARCH | 2004-02-05 | — | — | US | disclosed |
| WO-2003088975-A1 | INHIBITION OF FATTY ACID SYNTHASE BY BETA-LACTONES AND OTHER COMPOUNDS FOR INHIBITION OF CELLULAR PROLIFERATION | THE BURNHAM INSTITUTE (US) | 2003-10-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100173982-A1 | NOVEL METHOD FOR THE ASYMMETRIC SYNTHESIS OF BETA-LACTONE COMPOUNDS | FASN, COASY, FADS1 | DAGLA 228/4885PNLIP 88/4885CNR1 1240/4885 |
| US-20060258620-A1 | Novel method for the asymmetric synthesis of beta-lactone compounds | FASN, COASY, FADS1 | DAGLA 228/4885PNLIP 88/4885CNR1 1240/4885 |
| US-20040024050-A1 | Inhibition of fatty acid synthase by beta-lactones and other compounds for inhibition of cellular proliferation | FASN, FADS1, FADS2 | DAGLA 275/4885PNLIP 64/4885CNR1 1333/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.